Related Experiment Video
Updated: May 5, 2026

11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
7.1K
Functionalized polymeric nanomaterials for BMP-2 delivery: recent advances toward improved bone regeneration
Zhengang Wang1, Liyuan Zheng2, Guoqi Li3
1Department of Spinal Orthopedics, Changchun Jirun Jingyue Hospital, Changchun, China.
Nanomedicine (London, England)
|May 4, 2026
Summary
Polymeric nanotechnology offers solutions for bone morphogenic protein-2 (BMP-2) delivery, overcoming limitations like degradation and side effects for enhanced bone regeneration. This approach improves BMP-2 stability, targeting, and release kinetics for better therapeutic outcomes.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Nanotechnology
Background:
- Bone morphogenic protein-2 (BMP-2) is crucial for bone formation but faces clinical challenges due to rapid degradation and side effects.
- Current limitations hinder BMP-2's therapeutic potential in bone repair and regenerative medicine.
Purpose of the Study:
- To review advancements in polymeric nanotechnology for controlled and localized BMP-2 delivery.
- To critically examine functionalized nanocarriers for BMP-2 in bone tissue engineering.
Main Methods:
- Literature review of studies (2006-2026) from Web of Science, Scopus, and PubMed.
- Analysis of polymeric nanocarriers, surface functionalization, ligand conjugation, and stimuli-responsive designs.
- Evaluation of in-vitro and in-vivo studies on BMP-2 delivery systems.
Main Results:
- Polymeric nanotechnology enables controlled, localized, and sustained BMP-2 release, enhancing stability and targeting.
- Functionalized nanocarriers show promise for improving the therapeutic index of BMP-2.
- Combining bioresponsive elements with nanoarchitectural motifs can mimic the natural ECM for bone regeneration.
Conclusions:
- Advanced polymeric nanocarriers offer a promising strategy for overcoming BMP-2 delivery challenges in bone regeneration.
- Tailored nanocarrier design is key to improving BMP-2 efficacy and safety.
- Future strategies should focus on recapitulating the native microenvironment for next-generation bone tissue engineering therapies.

